Cozzolino Claudia, Mao Sofia, Bassan Francesco, Bilato Laura, Compagno Linda, Salvò Veronica, Chiusaroli Lorenzo, Cocchio Silvia, Baldo Vincenzo
Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, 35128 Padua, Italy.
Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padua, 35128 Padua, Italy.
Artif Intell Med. 2025 Jul;165:103137. doi: 10.1016/j.artmed.2025.103137. Epub 2025 Apr 22.
Healthcare-associated infections (HAIs) are a global public health concern, imposing significant clinical and financial burdens. Despite advancements, surveillance methods remain largely manual and resource-intensive, often leading to underreporting. In this context, automation, particularly through Artificial Intelligence (AI), shows promise in optimizing clinical workflows. However, adoption challenges persist. This study aims to evaluate the current performance and impact of AI in HAI surveillance, considering technical, clinical, and implementation aspects. We conducted a systematic review of Scopus and Embase databases following PRISMA guidelines. AI-based models' performances, accuracy, AUC, sensitivity, and specificity, were pooled using a random-effect model, stratifying by detected HAI type. Our study protocol was registered in PROSPERO (CRD42024524497). Of 2834 identified citations, 249 studies were reviewed. The performances of AI models were generally high but with significant heterogeneity between HAI types. Overall pooled sensitivity, specificity, AUC, and accuracy were respectively 0.835, 0.899, 0.864, and 0.880. About 35.7 % of studies compared AI system performance with alternative automated or standard-of-care surveillance methods, with most achieving better or comparable results to clinical scores or manual surveillance. <7.6 % explicitly measured AI impact in terms of improved patient outcomes, workload reduction, and cost savings, with the majority finding benefits. Only 30 studies deployed the model in a user-friendly tool, and 9 tested it in real clinical practice. In this systematic review, AI shows promising performance in HAI surveillance, although its routine application in clinical practice remains uncommon. Despite over a decade, retrieved studies offer scant evidence on reducing burden, costs, and resource use. This prevents their potential superiority over traditional or simpler automated surveillance systems from being fully evaluated. Further research is necessary to assess impact, enhance interpretability, and ensure reproducibility.
医疗保健相关感染(HAIs)是一个全球公共卫生问题,带来了巨大的临床和经济负担。尽管取得了进展,但监测方法在很大程度上仍然是人工的且资源密集型,常常导致报告不足。在这种背景下,自动化,特别是通过人工智能(AI),在优化临床工作流程方面显示出前景。然而,采用方面的挑战依然存在。本研究旨在从技术、临床和实施方面评估AI在HAI监测中的当前性能和影响。我们按照PRISMA指南对Scopus和Embase数据库进行了系统综述。基于AI的模型的性能、准确性、AUC、敏感性和特异性,使用随机效应模型进行汇总,并按检测到的HAI类型分层。我们的研究方案已在PROSPERO(CRD42024524497)中注册。在识别出的2834条引文中,对249项研究进行了综述。AI模型的性能总体较高,但不同HAI类型之间存在显著异质性。总体汇总敏感性、特异性、AUC和准确性分别为0.835、0.899、0.864和0.880。约35.7%的研究将AI系统性能与替代的自动化或护理标准监测方法进行了比较,大多数研究取得了比临床评分或人工监测更好或相当的结果。<7.6%的研究明确衡量了AI在改善患者结局、减少工作量和节省成本方面的影响,大多数研究发现了益处。只有30项研究将模型部署在用户友好的工具中,9项研究在实际临床实践中进行了测试。在这项系统综述中,AI在HAI监测中显示出有前景的性能,尽管其在临床实践中的常规应用仍然不常见。尽管已经过去了十多年,但检索到的研究提供的关于减轻负担、成本和资源使用的证据很少。这使得无法充分评估它们相对于传统或更简单的自动化监测系统的潜在优势。需要进一步的研究来评估影响、增强可解释性并确保可重复性。